These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Radioimmunotherapy of PANC-1 Human Pancreatic Cancer Xenografts in NRG Mice with Panitumumab Modified with Metal-Chelating Polymers Complexed to Aghevlian S; Cai Z; Lu Y; Hedley DW; Winnik MA; Reilly RM Mol Pharm; 2019 Feb; 16(2):768-778. PubMed ID: 30589553 [TBL] [Abstract][Full Text] [Related]
3. Radioimmunotherapy of PANC-1 human pancreatic cancer xenografts in NOD/SCID or NRG mice with Panitumumab labeled with Auger electron emitting, Aghevlian S; Cai Z; Hedley D; Winnik MA; Reilly RM EJNMMI Radiopharm Chem; 2020 Nov; 5(1):22. PubMed ID: 33169241 [TBL] [Abstract][Full Text] [Related]
4. Radioimmunotherapy of human pancreatic cancer xenografts in NOD-scid mice with [ Boyle AJ; Cao PJ; Cai Z; Chan C; Hedley DW; Reilly RM Nucl Med Biol; 2020; 84-85():46-54. PubMed ID: 32062317 [TBL] [Abstract][Full Text] [Related]
7. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates. Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962 [TBL] [Abstract][Full Text] [Related]
8. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384 [TBL] [Abstract][Full Text] [Related]
9. Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles. Yook S; Lu Y; Jeong JJ; Cai Z; Tong L; Alwarda R; Pignol JP; Winnik MA; Reilly RM Biomacromolecules; 2016 Apr; 17(4):1292-302. PubMed ID: 26974228 [TBL] [Abstract][Full Text] [Related]
10. Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu. Yook S; Cai Z; Lu Y; Winnik MA; Pignol JP; Reilly RM Mol Pharm; 2015 Nov; 12(11):3963-72. PubMed ID: 26402157 [TBL] [Abstract][Full Text] [Related]
11. Dose predictions for [ Ku A; Kondo M; Cai Z; Meens J; Li MR; Ailles L; Reilly RM EJNMMI Radiopharm Chem; 2021 Aug; 6(1):25. PubMed ID: 34383182 [TBL] [Abstract][Full Text] [Related]
12. MicroPET/CT imaging of patient-derived pancreatic cancer xenografts implanted subcutaneously or orthotopically in NOD-scid mice using (64)Cu-NOTA-panitumumab F(ab')2 fragments. Boyle AJ; Cao PJ; Hedley DW; Sidhu SS; Winnik MA; Reilly RM Nucl Med Biol; 2015 Feb; 42(2):71-7. PubMed ID: 25456837 [TBL] [Abstract][Full Text] [Related]
13. Local Radiation Treatment of HER2-Positive Breast Cancer Using Trastuzumab-Modified Gold Nanoparticles Labeled with Cai Z; Yook S; Lu Y; Bergstrom D; Winnik MA; Pignol JP; Reilly RM Pharm Res; 2017 Mar; 34(3):579-590. PubMed ID: 27987070 [TBL] [Abstract][Full Text] [Related]
14. Alpha radioimmunotherapy using Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220 [TBL] [Abstract][Full Text] [Related]
15. 177Lu-labeled antibodies for EGFR-targeted SPECT/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model. Liu Z; Ma T; Liu H; Jin Z; Sun X; Zhao H; Shi J; Jia B; Li F; Wang F Mol Pharm; 2014 Mar; 11(3):800-7. PubMed ID: 24472064 [TBL] [Abstract][Full Text] [Related]
17. Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent Vaughn BA; Lee SG; Vargas DB; Seo S; Rinne SS; Xu H; Guo HF; Le Roux AB; Gajecki L; Krebs S; Yang G; Ouerfelli O; Zanzonico PB; Fung EK; St Jean S; Carrasco SE; Jungbluth A; Cheung NKV; Larson SM; Veach DR; Cheal SM J Nucl Med; 2024 Oct; 65(10):1611-1618. PubMed ID: 39168519 [TBL] [Abstract][Full Text] [Related]
18. Metal-Chelating Polymers (MCPs) with Zwitterionic Pendant Groups Complexed to Trastuzumab Exhibit Decreased Liver Accumulation Compared to Polyanionic MCP Immunoconjugates. Liu P; Boyle AJ; Lu Y; Adams J; Chi Y; Reilly RM; Winnik MA Biomacromolecules; 2015 Nov; 16(11):3613-23. PubMed ID: 26469142 [TBL] [Abstract][Full Text] [Related]
19. Trastuzumab Labeled to High Specific Activity with (111)In by Site-Specific Conjugation to a Metal-Chelating Polymer Exhibits Amplified Auger Electron-Mediated Cytotoxicity on HER2-Positive Breast Cancer Cells. Ngo Ndjock Mbong G; Lu Y; Chan C; Cai Z; Liu P; Boyle AJ; Winnik MA; Reilly RM Mol Pharm; 2015 Jun; 12(6):1951-60. PubMed ID: 25919639 [TBL] [Abstract][Full Text] [Related]